Holen Sie sich die Stockscreener-App
4.83
0.82%
-0.04
Handel nachbörslich:
4.84
0.010
+0.21%
Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
6.6819 | 4.2348 | 2.4723 | 3.0789 |
Operating Expenses
|
16.98%
3.9083
|
3.3409 | 2.1174 | 1.2362 | 1.5395 |
| Interest Income/Expense |
269.68%
0.00796
|
0.00215 | 0.00534 | 0.00913 | 0.00735 |
| Depreciation and Amortization |
100.00%
-
|
0.00471 | 0.000969 | 0.001 | 0.000895 |
| Operating Income/Loss |
216.98%
-3.9083
|
3.3409 | 2.1174 | 1.2362 | 1.5395 |
| Income/Loss From Continuing Operations Before Tax |
17.77%
-3.7988
|
-3.2256 | 1.972 | -1.1063 | -1.4068 |
| Income/Loss From Continuing Operations After Tax |
17.77%
-3.7988
|
-3.2256 | 1.972 | -1.1063 | -1.4068 |
|
Net Income/Loss
|
17.77%
-3.7988
|
-3.2256 | 1.972 | -1.1063 | -1.4068 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
17.77%
-7.5977
|
-6.4512 | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):